Search Results 881-890 of 19800 for Receptor

  1. Study of INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma - Mayo Clinic

    ... receptor-1/Programmed Death receptor Ligand-1 (anti-PD-1/PD-L1) therapy; Cohort B: Participants with locally advanced unresectable or metastatic/recurrent ...

  2. Publications - Mabel Ryder, M.D. - Mayo Clinic

    Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma. J Nucl Med. 2026 Jan ...

  3. COVID-19 expert answers questions on how the virus makes people sick and more

    The case fatality rate is probably about 10 times higher than influenza. This particular virus is very efficiently adapted to find those receptors, bind tightly ...

  4. MC1R-targeted Alpha-particle Monotherapy And Combination Therapy Trial With Nivolumab In Adults With Advanced Melanoma - Mayo Clinic

    ... receptor (MC1R) is being evaluated as a monotherapy and in combination with Nivolumab in subjects with unresectable and metastatic melanoma. Participation ...

  5. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    Incretin-modifying agents, including glucagon-like peptide-1 (GLP-1) receptor agonists, are emerging as the most promising drug treatments for obesity ...

  6. The brain-heart connection: Mayo Clinic expert explains powerful tie that works both ways

    "At the same time, the heart sends signals back to the brain through nerves, hormones, and pressure receptors — affecting our mood, attention, and stress levels ...

  7. June 10, 2013 Joe Dangor 507-284-5005 (days) 507-284-2511 (evenings) Email: newsbureau@mayo.edu Genetic Variations May Help Ide

    that selective estrogen receptor modulators (SERM) therapy with tamoxifen and raloxifene can lower a woman's risk for developing breast cancer. However ...

  8. A Study of the Safety and Effectiveness of Combined Copaxone and Estriol for Relapsing Remitting Multiple Sclerosis - Mayo Clinic

    ... receptor alpha (ERalpha). Gold SM. Stefan M; Sasidhar MV. Manda V; Morales LB. Laurie B; Du S. Sienmi; Sicotte NL. Nancy L; Tiwari-Woodruff SK. Seema K ...

  9. Publications - Mike S. Bold, M.D. - Mayo Clinic

    ... receptor inhibitor. Haematologica 2020 Nov 1; 105 (11):2675-2678 Epub 2020 Nov 01. View PubMed; Wang Y, Rabe KG, Bold MS, Shi M, Hanson CA, Schwager SM, Call ...

  10. Dev Mukhopadhyay, Ph.D. - Mayo Clinic Faculty Profiles

    Mukhopadhyay and his team are developing models to quantitatively assess the cumulative contributions of the involved receptors ... receptor (IGF-1R) expression ...